{"nct_id":"NCT04520451","title":"Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2020-08-22","start_date_type":"ACTUAL","primary_completion_date":"2024-10-15","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-15","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}